- HMRC has extended VAT zero-rating for drugs and medicines dispensed in accordance with a patient group direction.
- The change applies for drugs and medicines supplied between 9 October 2023 and 31 March 2027.
- The VAT treatment is being updated to reflect the way healthcare professionals supply drugs and medicines to patients.
- A patient group direction allows for the provision of specified drugs to a pre-defined group of patients without prescription.
- The order brings the treatment of these supplies in line with the VAT treatment of drugs dispensed on prescription to individual patients.
Source: taxjournal.com
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "United Kingdom"
- UK Considers VAT Cut on Domestic Fuel: Targeted Relief or Broad Measure?
- Supreme Court Clarifies VAT Grouping and Time of Supply Rules in Prudential Assurance Case
- Guernsey Seeks Companies to Support New GST Administration, Tender Deadline Approaches
- Navigating UK VAT: Key Considerations and Pitfalls in Exporting Goods
- HMRC’s New VAT Error Correction Rules: Stricter Penalties and Reporting Changes Explained
